The drugs glass packaging market will grow from USD 5.51 billion in 2025 to USD 8.17 billion by 2034, at a CAGR of 5.05% during the forecast period.
New Advancements in the Drug Glass Packaging Industry
- In October 2024, Nipro PharmaPackaging, a leader in medical devices, glass tubing, and glass primary packaging, revealed the introduction of the D2F (Direct-To-Fill) glass vials. With the help of Stevanato Group’s cutting-edge EZ-fill technology, these vials provide a premium ready-to-use (RU) solution made to satisfy the exacting standards and growing demand of the pharmaceutical sector.
- In January 2025, SGD Pharma, a leader in the pharmaceutical glass primary packaging solutions market worldwide, showcased its cutting-edge line of goods and services at Pharmapack at booths B55 and B59. Among these is its platform Sealian, an internal treatment that improves the functionality of molded glass vials. Pharmapack, the premier European pharmaceutical packaging trade event, will take place in Paris, France.
Recent Developments
- In August 2024, Eli Lilly, announced the launch of a low-price weight loss drug without an injector pen. It is part of a new class of medications used to treat obesity and diabetes.
- In November 2023, Becton Dickinson, announced the launch of a glass prefillable syringe (PFS). The syringe reduces the risk of line stoppage and improves the total cost of ownership, manufacturing capacity, and supply availability.
Drugs Glass Packaging Market Companies
Become a valued research partner with us, please feel free to contact us at sales@towardspackaging.com
